Clinical trials
Acute Coronary Syndrome trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 18 |
| Recruiting | 11 |
| Completed | 8 |
| Not yet recruiting | 6 |
| Active, not recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Harbin Medical University | 4 |
| China National Center for Cardiovascular Diseases | 3 |
| Beijing AmsinoMed Medical Device Co., Ltd | 2 |
| Beijing Anzhen Hospital | 2 |
| Qilu Hospital of Shandong University | 2 |
| Shenyang Northern Hospital | 2 |
| The George Institute for Global Health, China | 2 |
| Xijing Hospital | 2 |
| Beijing Friendship Hospital | 1 |
| Capital Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 47 |
| Coronary Disease | 5 |
| Coronary Artery Disease | 4 |
| Myocardial Ischemia | 4 |
| ST Elevation Myocardial Infarction | 4 |
| Arterial Occlusive Diseases | 2 |
| Cardiovascular Diseases | 2 |
| Hemorrhage | 2 |
| Acute Aortic Syndrome | 1 |
| Angina, Stable | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.